Investor FAQ

Who can invest?

Before we go further, it's important to make sure this opportunity is suitable for you.

This is a very early-stage company and should be treated as high-risk, long-term equity.

We are raising under SEIS, which may offer tax reliefs for eligible UK taxpayers, but investors should be comfortable that they could lose all of their investment, and that shares are illiquid for at least three years.

If that profile suits you, you can contact us for more information and a pitch deck.

Why invest now?

You're first in. TherAIpy is a rare, well-timed opportunity in a booming market with a world-class team and protection from GenAI commodification.

We're immune to AI market volatility. Unlike chatbot wrappers racing to the bottom, our value is human connection and expertise, something LLMs can't replicate. 

Mental health demand isn't slowing. This market is projected to keep growing regardless of AI hype cycles.

SEIS tax benefits: £10K investment = £5K immediate income tax relief for top-rate taxpayers. Hold 3 years for CGT-free gains. Check your own tax status to be clear on your individual options.

What returns are you targeting?

30-40x return within 2-3 years via Series A/B exits. Obviously not guaranteed, and completely hypothetical, but confidence in this as a valid projection comes from:

• Lean, disciplined spending (founder has worked on multiple startups) 
• Profit-share model that covers production costs upfront on every sale
• Unit economics improve with scale
• A global unsatisfied marketplace
• A massive existing market of customers (therapists) plus many already commited to training such as psychology students, who will be looking for ways to take their training into a career.

We're not kicking the can down the road. This model is built to reach profitability without endless funding rounds.

Why will this work in a crowded AI market?

We're not competing with normal AI: we're empowering humans with it.

• GenAI platforms commoditize and race to the bottom
• We remain immune because our value is human expertise, not synthetic content
• We help 21M+ trained therapists stay relevant and profitable (Statista, 2024)
• We believe that as long as people need people, TherAIpy grows

Who are your customers and why will they buy?

Primary: Therapists, coaches, counselors (UK: 690K, Global: 21M+, Statista 2025).

Future expansion: Teachers, nurses, nutritionists, yoga instructors, parents, then B2C.

Why they'll pay:

• Solves biggest pain points: high costs, weak marketing, high end prices, staying relevant in the AI age
• Boosts visibility and integrates seamlessly into existing practices 
• Dramatically broadens the scope of products and options they can offer their end customers
• Training replaces expensive CPD (£300-£700) with practical learning at ~15% of normal cost

B2C comes later—like Bentley selling baseball caps after establishing the brand with flagship cars. Therapists create the market; B2C follows.

Long-term opportunities: NHS partnerships, insurers (timing dependent on admin cycles, not product capability).

Can I get a demo?

Yes, once we've assessed your intent. 

What does my money fund?

70% Technology:

• Treatment generation engine
• AI voice delivery system
• Automation for scaling to thousands of therapists

30% Launch & Testing:

• Recruit first 50 beta therapists
• Prove concept for Series A investors
• Essential admin: legal, accounting, customer support

What's the timeline?

• April 2026: SEIS round opens, capital deployed immediately
• September 2026: Public beta launch (subject to funding) 
• 24-36 months: Target major value acceleration and Series A opportunity

Investment range?

£10K - £250K

What involvement do I get?

You can contribute ideas. Voting rights reserved for lead investor only.

How good is the team?

World-class with relevant experience.

• Simon Richards (Founder) – Certified hypnotherapist/psychotherapist, digital innovator with global brands, leading design on HSBC's flagship AI product, working with Anthropic, former award-winning TV/radio producer
• Gareth Strangemore-Jones – One of UK's most qualified therapists, content creator, PR expert
• Dr. Scott Wellington – AI Voice PhD, built matching systems in MedTech space
• Code With Feeling – 20+ year partnership with Simon across 50+ projects including HSBC's AI platform
• Dr. Tory Frame – Oxford, Harvard MBA, AI PhD, global strategy leader
• Plus: Oxford-educated linguist (content), practicing therapists (live testing), secure AWS DevOps partner

I'm a therapist, can I get involved?

Yes, we do have plans to test the product with beta testing therapists, and also work with them to look at content development. Please email us to find out more.

What about diversity and inclusion?

Built-in, not bolted-on. TherAIpy makes it equally easy to create tailored treatments for niche needs (e.g., LGBT+ teenage refugee with social anxiety) as common issues (smoking cessation). We're interested in levelling the playing field for the people who need therapy. 

Team includes LGBT+, women, racial minorities, and neurodivergent members—here for talent and impact, not checkboxes.